Stem Cell Therapeutics Advances CD47 Antagonist Program Into IND-Enabling … – MENAFN.COM
|
Stem Cell Therapeutics Advances CD47 Antagonist Program Into IND-Enabling …
MENAFN.COM TORONTO, ONTARIO, Sep 09, 2013 (Menafn – Marketwired via COMTEX) —Stem Cell Therapeutics Corp. (otcqx:SCTPF), abiopharmaceutical company developing cancer stem cell– relatedtherapeutics, today announced that it has advanced its … |
